AAAAAA
Results: 1-25/130
Authors:
ESSINKBOT ML
DEKONING HJ
NIJS HGT
KIRKELS WJ
VANDERMAAS PJ
SCHRODER FH
Citation: Ml. Essinkbot et al., SHORT-TERM EFFECTS OF POPULATION-BASED SCREENING FOR PROSTATE-CANCER ON HEALTH-RELATED QUALITY-OF-LIFE, Journal of the National Cancer Institute, 90(12), 1998, pp. 925-931
Authors:
VANWEERDEN WM
DERIDDER CMA
ROMIJN JC
VANSTEENBRUGGE GJ
SCHRODER FH
Citation: Wm. Vanweerden et al., A PANEL OF XENOGRAFT MODELS REPRESENTATIVE FOR HUMAN PROSTATE-CANCER AS A USEFUL TOOL IN THE FIELD OF NEW DRUG DEVELOPMENT AND PRECLINICAL DRUG-TESTING, Annals of oncology, 9, 1998, pp. 151-151
Authors:
VANBRUSSEL JP
VANSTEENBRUGGE GJ
VANKRIMPEN C
VANDERKWAST TH
BOGDANOWICZ JFAT
SCHRODER FH
MICKISCH GH
Citation: Jp. Vanbrussel et al., EXPRESSION OF PROTEINS ASSOCIATED WITH MULTIDRUG-RESISTANCE (MDR) ANDTOPOISOMERASE (TOPO) ENZYMES IN LOCALLY CONFINED, METASTATIC AND HORMONE-REFRACTORY PROSTATE-CANCER (PC), Annals of oncology, 9, 1998, pp. 235-235
Authors:
VERKOELEN CF
VANDERBOOM BG
HOUTSMULLER AB
SCHRODER FH
ROMIJN JC
Citation: Cf. Verkoelen et al., INCREASED CALCIUM-OXALATE MONOHYDRATE CRYSTAL BINDING TO INJURED RENAL TUBULAR EPITHELIAL-CELLS IN CULTURE, American journal of physiology. Renal, fluid and electrolyte physiology, 43(5), 1998, pp. 958-965
Authors:
SCHRODER FH
Citation: Fh. Schroder, ANTIANDROGENS AS MONOTHERAPY FOR PROSTATE-CANCER, European urology, 34, 1998, pp. 12-17
Authors:
DEVOOGT HJ
STUDER U
SCHRODER FH
KLIJN JG
DEPAUW M
SYLVESTER R
Citation: Hj. Devoogt et al., MAXIMUM ANDROGEN BLOCKADE USING LHRH AGONIST BUSERELIN IN COMBINATIONWITH SHORT-TERM (2 WEEKS) OR LONG-TERM (CONTINUOUS) CYPROTERONE-ACETATE IS NOT SUPERIOR TO STANDARD ANDROGEN DEPRIVATION IN THE TREATMENT OF ADVANCED PROSTATE-CANCER - FINAL ANALYSIS OF EORTC GU GROUP TRIAL-30843, European urology, 33(2), 1998, pp. 152-158
Authors:
KONIG JJ
TEUBEL W
KAMST E
ROMIJN JC
SCHRODER FH
HAGEMEIJER A
Citation: Jj. Konig et al., CYTOGENETIC ANALYSIS OF 39 PROSTATE CARCINOMAS AND EVALUATION OF SHORT-TERM TISSUE-CULTURE TECHNIQUES, Cancer genetics and cytogenetics, 101(2), 1998, pp. 116-122
Authors:
RIETBERGEN JBW
KRANSE R
HOEDEMAEKER RF
KRUGER AEB
BANGMA CH
KIRKELS WJ
SCHRODER FH
Citation: Jbw. Rietbergen et al., COMPARISON OF PROSTATE-SPECIFIC ANTIGEN CORRECTED FOR TOTAL PROSTATE VOLUME AND TRANSITION ZONE VOLUME IN A POPULATION-BASED SCREENING STUDY, Urology, 52(2), 1998, pp. 237-246
Authors:
SCHRODER FH
KRANSE R
Citation: Fh. Schroder et R. Kranse, PERCENTAGE OF FREE SERUM PROSTATE-SPECIFIC ANTIGEN AS A PREDICTOR OF PATHOLOGICAL FEATURES OF PROSTATE-CANCER IN A SCREENING POPULATION - COMMENT, Urology, 51(4), 1998, pp. 564-565
Authors:
WEIJERMAN PC
ZHANG Y
SHEN JC
DUBBINK HJ
ROMIJN JC
PEEHL DM
SCHRODER FH
Citation: Pc. Weijerman et al., EXPRESSION OF PROSTATIC FACTORS MEASURED BY REVERSE TRANSCRIPTION-POLYMERASE CHAIN-REACTION IN HUMAN-PAPILLOMAVIRUS TYPE-18 DEOXYRIBONUCLEIC-ACID IMMORTALIZED PROSTATE CELL-LINES, Urology, 51(4), 1998, pp. 657-662
Authors:
WEIJERMAN PC
SCHURMANS JR
HOP WCJ
SCHRODER FH
BOSCH JLHR
Citation: Pc. Weijerman et al., MORBIDITY AND QUALITY-OF-LIFE IN PATIENTS WITH ORTHOTOPIC AND HETEROTOPIC CONTINENT URINARY-DIVERSION, Urology, 51(1), 1998, pp. 51-56
Authors:
VANDENOUDEN D
KRANSE R
HOP WCJ
VANDERKWAST TH
SCHRODER FH
Citation: D. Vandenouden et al., MICROVASCULAR INVASION IN PROSTATE-CANCER - PROGNOSTIC-SIGNIFICANCE IN PATIENTS TREATED BY RADICAL PROSTATECTOMY FOR CLINICALLY LOCALIZED CARCINOMA, Urologia internationalis, 60(1), 1998, pp. 17-24
Authors:
RIETBERGEN JBW
KRUGER AEB
HOEDEMAEKER RF
BANGMA CH
KIRKELS WJ
SCHRODER FH
Citation: Jbw. Rietbergen et al., REPEAT SCREENING FOR PROSTATE-CANCER AFTER 1-YEAR FOLLOW-UP IN 984 BIOPSIED MEN - CLINICAL AND PATHOLOGICAL FEATURES OF DETECTED CANCER, The Journal of urology, 160(6), 1998, pp. 2121-2125
Authors:
VANDENOUDEN D
HOP WCJ
SCHRODER FH
Citation: D. Vandenouden et al., PROGRESSION IN AND SURVIVAL OF PATIENTS WITH LOCALLY ADVANCED PROSTATE-CANCER (T3) TREATED WITH RADICAL PROSTATECTOMY AS MONOTHERAPY, The Journal of urology, 160(4), 1998, pp. 1392-1397
Authors:
VANDERKWAST TH
HOEDEMAEKER RF
KRANSE R
RIETBERGEN JBW
KRUGER AEB
SCHRODER FH
Citation: Th. Vanderkwast et al., INCIDENCE OF HIGH-GRADE INTRAEPITHELIAL NEOPLASIA AND SUSPECT LESIONSIN SYSTEMATIC SEXTANT PROSTATE NEEDLE BIOPSIES IN A POPULATION-BASED SCREENING STUDY (ERSPC), The Journal of urology, 159(5), 1998, pp. 689-689
Authors:
SCHELTEMA JMW
VANSTEENBRUGGE GJ
ROMIJN JC
SCHRODER FH
MICKISCH GH
Citation: Jmw. Scheltema et al., CHEMORESISTANCE OF RENAL-CELL CARCINOMA DUE TO INHIBITION OF APOPTOSIS, The Journal of urology, 159(5), 1998, pp. 747-747
Authors:
SCHRODER FH
KRUGER AB
HOEDEMAEKER RF
KRANSE R
RIETBERGEN J
Citation: Fh. Schroder et al., EUROPEAN RANDOMIZED STUDY OF SCREENING FOR PROSTATE-CANCER (ERSPC) - THE ACCURACY OF DRE AND PSA TRANSITION ZONE DENSITY IN DIAGNOSING PROSTATE-CANCER, The Journal of urology, 159(5), 1998, pp. 891-891
Authors:
SCHRODER FH
WHELAN P
KURTH KH
DEPAUW M
Citation: Fh. Schroder et al., ANTIANDROGEN MONOTHERAPY - IS SEXUAL FUNCTION PRESERVED IN PATIENTS WITH PROSTATE-CANCER (PC), The Journal of urology, 159(5), 1998, pp. 1292-1292
Authors:
BANGMA CH
RIETBERGEN JBW
KRANSE R
BLIJENBERG BG
PETTERSON K
SCHRODER FH
Citation: Ch. Bangma et al., THE FREE-TO-TOTAL PROSTATE-SPECIFIC ANTIGEN RATIO IMPROVES THE SPECIFICITY OF PROSTATE-SPECIFIC ANTIGEN IN SCREENING FOR PROSTATE-CANCER INTHE GENERAL-POPULATION - REPLY, The Journal of urology, 159(3), 1998, pp. 994-995
Authors:
ALERS JC
KRIJTENBURG PJ
HOP WCJ
BOLLE WABM
SCHRODER FH
VANDERKWAST TH
BOSMAN FT
VANDEKKEN H
Citation: Jc. Alers et al., LONGITUDINAL EVALUATION OF CYTOGENETIC ABERRATIONS IN PROSTATIC-CANCER - TUMORS THAT RECUR IN TIME DISPLAY AN INTERMEDIATE GENETIC STATUS BETWEEN NONPERSISTENT AND METASTATIC TUMORS, Journal of pathology, 185(3), 1998, pp. 273-283
Authors:
KLIJN AJ
HOP WCJ
MICKISCH G
SCHRODER FH
BOSCH JLHR
Citation: Aj. Klijn et al., THE ARTIFICIAL URINARY SPHINCTER IN MEN INCONTINENT AFTER RADICAL PROSTATECTOMY - 5-YEAR ACTUARIAL ADEQUATE FUNCTION RATES, British Journal of Urology, 82(4), 1998, pp. 530-533
Authors:
NOORDZIJ MA
VANSTEENBRUGGE GJ
VERKAIK NS
SCHRODER FH
VANDERKWAST TH
Citation: Ma. Noordzij et al., THE PROGNOSTIC VALUE OF CD44 ISOFORMS IN PROSTATE-CANCER PATIENTS TREATED BY RADICAL PROSTATECTOMY, Clinical cancer research, 3(5), 1997, pp. 805-815
Authors:
BLIJENBERG BG
BANGMA CH
KRANSE R
EMAN I
SCHRODER FH
Citation: Bg. Blijenberg et al., ANALYTICAL EVALUATION OF THE NEW PROSTATUS(TM) PSA FREE TOTAL ASSAY FOR PROSTATE-SPECIFIC ANTIGEN AS PART OF A SCREENING STUDY FOR PROSTATE-CANCER/, European journal of clinical chemistry and clinical biochemistry, 35(2), 1997, pp. 111-114
Authors:
HOEDEMAEKER RF
RIETBERGEN JBW
KRANSE R
VANDERKWAST TH
SCHRODER FH
Citation: Rf. Hoedemaeker et al., COMPARISON OF PATHOLOGICAL CHARACTERISTICS OF T1C AND NON-T1C CANCERSDETECTED IN A POPULATION-BASED SCREENING STUDY, THE EUROPEAN RANDOMIZED STUDY OF SCREENING FOR PROSTATE-CANCER, World journal of urology, 15(6), 1997, pp. 339-345
Authors:
VERKOELEN CF
VANDERBOOM BG
SCHRODER FH
ROMIJN JC
Citation: Cf. Verkoelen et al., CELL-CULTURES AND NEPHROLITHIASIS, World journal of urology, 15(4), 1997, pp. 229-235